Smith Group Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-282,047
| Closed | -$20.7M | – | 353 |
|
|
2020
Q4 | $20.7M | Sell |
282,047
-14,650
| -5% | -$1.07M | 1.2% | 33 |
|
|
2020
Q3 | $23.1M | Buy |
296,697
+292,557
| +7,067% | +$22.7M | 1.2% | 24 |
|
|
2020
Q2 | $230K | Sell |
4,140
-70
| -2% | -$3.89K | 0.01% | 159 |
|
|
2020
Q1 | $125K | Hold |
4,210
| – | – | 0.01% | 196 |
|
|
2019
Q4 | $152K | Hold |
4,210
| – | – | 0.01% | 218 |
|
|
2019
Q3 | $115K | Hold |
4,210
| – | – | ﹤0.01% | 229 |
|
|
2019
Q2 | $101K | Hold |
4,210
| – | – | ﹤0.01% | 238 |
|
|
2019
Q1 | $111K | Sell |
4,210
-92,150
| -96% | -$2.43M | ﹤0.01% | 252 |
|
|
2018
Q4 | $1.88M | Sell |
96,360
-2,270
| -2% | -$44.4K | 0.07% | 132 |
|
|
2018
Q3 | $1.93M | Buy |
+98,630
| New | +$1.93M | 0.05% | 135 |
|